Navigation Links
New Drug Promises Prolonged Survival in Prostate Cancer Patients

A new anti-cancer drug called pertuzumab, shows promise in slowing progression and prolonging survival time in men with prostate cancer.//

A new class of targeted anti-cancer drugs that blocks the human epidermal growth factor (HER) receptor family shows promise in prolonging the lives of patients with recurrent prostate cancer, a new Cedars-Sinai study shows. The drug, a molecular targeted compound called pertuzumab, works by binding to and inhibiting the function of HER2 receptors, interrupting a key pathway that leads to cancer growth.

The study, published in the February 20 issue of the Journal of Clinical Oncology, involved 41 patients with treatment-resistant prostate cancer who had experienced progression of their disease after prior chemotherapy. Patients received the drug every three weeks until disease progression. MRI and CAT scans were used to evaluate the tumors during the period of drug therapy. While no shrinkage of tumors was reported, retrospective analysis showed that survival rate was prolonged to 16.4 months with the drug as compared to a median average of 10.7 months in a historical control group with similar baseline prognostic features.

“Advanced prostate cancer is difficult to treat – and the drug therapies currently available to these patients have not been very effective, especially in patients whose disease has progressed after chemotherapy treatment,” said David B. Agus, M.D., principal investigator of the study and research director of Cedars-Sinai’s Louis Warschaw Prostate Cancer Center at the Samuel Oschin Comprehensive Cancer Institute. “Pertuzumab may offer a new treatment approach for these patients when it is evaluated as a tool to slow – not stop or shrink -- tumor growth.”

“The theory is that by significantly slowing progression of the cancer, patients will experience a good quality of life for a longer period of time,” said Agus. “Ultimately, we hope drugs like pertuzumab will help
'"/>




Page: 1 2 3

Related medicine news :

1. Marijuana-Derived Drug Promises Hope In Treating Bladder Infection
2. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
3. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
4. Maternal Vitamin D Supplementation Promises Healthy Bones In Child
5. Raw Vegan Diet Promises Lightweight, Healthy Bones
6. Stem Cell Transplantation Promises Cure for Type 2 Diabetes
7. New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment
8. Health Minister Promises Strict Quality Control On Herbal Medicines
9. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
10. Nanotechnology Promises Huge Medical Benefits
11. Health Minister Promises New Benchmark for Wait Times
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Drug Promises Prolonged Survival Prostate Cancer Patients

(Date:7/28/2014)... 28, 2014 Ticket Down is ... Champions Cup Match between Manchester City and Liverpool FC ... Bronx has hosted countless big events since it opened several ... of the original Yankee Stadium, however, it has been a ... City metro area. , The Yankees Stadium is the ...
(Date:7/28/2014)... UHY LLP, a member of the global ... International Business – Issue 29. This bi-annual publication features ... current business challenges and key issues faced by companies ... following topics:, , Key industry sectors ... the next five years? Where are growth opportunities to ...
(Date:7/28/2014)... students seem to be satisfied with the healthier school lunches ... school officials. , , New meal standards -- issued by ... the fall of 2012. At the time, there was concern ... of their food. But the new study of nearly 600 ... "The updated meals standards are resulting in healthier meals for ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Glutamine is ... and it’s considered to be conditionally essential during times ... is an advanced recovery & Immune System Support. , ... glutamine your body produces, supplementing with additional glutamine may ... waste products in the body, digestion and immune system ...
(Date:7/28/2014)... researchers report that an alternative to the traditional handshake ... experiments, the scientists found that clasping hands transferred about ... other than what is known as a fist bump. ... a cultural substitute for the firm gripping of hands. ... of the American Journal of Infection Control . ...
Breaking Medicine News(10 mins):Health News:Liverpool FC vs. Manchester City Tickets at Yankee Stadium: Ticket Down Reports Huge Demand for Guinness International Champions Cup Tickets in NYC 2Health News:Liverpool FC vs. Manchester City Tickets at Yankee Stadium: Ticket Down Reports Huge Demand for Guinness International Champions Cup Tickets in NYC 3Health News:Uhy International Business Issue 29 Now Available 2Health News:Uhy International Business Issue 29 Now Available 3Health News:Healthy School Lunches Get Thumbs Up From Students 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3
... A hospital group based in McAllen, Texas, has agreed to ... it violated the False Claims Act, the Anti-Kickback Statute and ... compensation to doctors in order to induce them to refer ... today. McAllen Hospitals L.P., d/b/a/ South Texas Health System, is ...
... , - Calls on Congress to Address Long Term ... 30 At a briefing by the Leadership Council of Aging ... Council on Aging (NCOA), applauded the House for making the CLASS ... Health Care for America Act and urged the Senate to include ...
... new drugs in pipeline , FRIDAY, Oct. 30 (HealthDay ... present a major public health problem, said scientists gathering ... Friday. , Chief among the concerns are resistant gram-negative ... and otherwise healthier people. The troubling trend is compounded ...
... more go up, study finds , FRIDAY, Oct. 30 (HealthDay ... dialysis, a U.K. study has found. , Researchers at the ... information on 69 dialysis patients who had traveled in Europe, ... Rim and South Asia. , One person died while traveling, ...
... , BIRMINGHAM, Ala., Oct. 30 WakeMed Health & ... a Letter of Understanding (LOU) under which the two ... http://www.newscom.com/cgi-bin/prnh/20080812/CLTU111LOGO ) , These opportunities may include WakeMed ... Blue Ridge Surgery Center with SCA continuing to manage ...
... new study from a researcher at Harvard University finds that ... while straight men prefer the most feminine-faced women. The ... wired for attraction to sexually dimorphic facesthose with facial features ... The research is currently published online in the journal ...
Cached Medicine News:Health News:Texas Hospital Group Pays U.S. $27.5 Million to Settle False Claims Act Allegations 2Health News:Texas Hospital Group Pays U.S. $27.5 Million to Settle False Claims Act Allegations 3Health News:National Council on Aging's Firman Lauds CLASS Act as Part of House Health Care Bill 2Health News:National Council on Aging's Firman Lauds CLASS Act as Part of House Health Care Bill 3Health News:Antibiotic Resistance Still a Major Public Health Threat 2Health News:Antibiotic Resistance Still a Major Public Health Threat 3Health News:Antibiotic Resistance Still a Major Public Health Threat 4Health News:WakeMed and Surgical Care Affiliates Enter into Venture for Ambulatory Surgery 2Health News:WakeMed and Surgical Care Affiliates Enter into Venture for Ambulatory Surgery 3Health News:For gay and straight men, facial attraction operates similarly 2
(Date:7/28/2014)... Reportbuyer.com has added a new market research ... https://www.reportbuyer.com/product/2225723/Global-Bone-Densitometers-Market-2014-2018.html ... special type of X-ray test used to measure the ... to detect osteopenia or osteoporosis, diseases in which the ... is high. The purpose of bone densitometry is to ...
(Date:7/28/2014)... -- June 28 th , 2014 – Oncolab, the ... cancer test, is making its AACC debut (booth #4051) at ... is a serum-based in vitro immunoassay, has been run for ... in the fight against cancer recurrence. Photo - ... million cancer survivors in the US alone, the race is ...
(Date:7/28/2014)...  Surgical Theater, LLC announced today the addition ... Board. New members include Ori J. Braun ... and New Technologies for Given Imaging Ltd., and ... President and General Manager of Philips Healthcare,s Computer ... technology to brain surgery and has developed software-based ...
Breaking Medicine Technology:Global Bone Densitometers Market 2014-2018 2Global Bone Densitometers Market 2014-2018 3Global Bone Densitometers Market 2014-2018 4Global Bone Densitometers Market 2014-2018 5Oncolab, Inc. Exhibits Pioneering AMAS Cancer Test at AACC 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 3Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 4Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 5
... FRANCISCO, Calif. , March 15 Poniard Pharmaceuticals, ... innovative oncology therapies, today announced the sale of 4,229,000 of ... Ltd. for gross proceeds of approximately $6.3 million , ... committed equity financing facility with Commerce Court.  Poniard intends to ...
... Caliper Life Sciences, Inc. (Nasdaq: CALP ), a ... life sciences research, today announces that it has entered into ... subsidiary Shimadzu Scientific Instruments, Inc., resolving a lawsuit filed by ... District of Texas that claimed that Shimadzu,s MultiNA ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces $6.3 Million Financing 2Poniard Pharmaceuticals Announces $6.3 Million Financing 3Poniard Pharmaceuticals Announces $6.3 Million Financing 4Caliper Settles Outstanding Litigation with Shimadzu 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: